Decorin–TGFβ Axis in Hepatic Fibrosis and Cirrhosis

Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice

(2010) Kornélia Baghy et al.   LABORATORY INVESTIGATION

Erratum: Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program

(2009) Guadalupe Garcia-Tsao et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Liver Fibrosis and Therapeutic Strategies: The Goal for Improving Metabolism

(2009) Clara Balsano et al.   CURRENT DRUG TARGETS

Treatment of HBV-related cirrhosis

(2009) Anais Vallet-Pichard et al.   Expert Review of Anti-Infective Therapy

¿Cuál es el tratamiento de elección en un paciente con cirrosis hepática y varices esofágicas que han sangrado, con objeto de prevenir el resangrado: bloqueadores beta, ligadura endoscópica, o ambas?

(2009) Agustín Albillos Martínez   Gastroenterologia y Hepatologia

Decorin is a novel antagonistic ligand of the Met receptor

(2009) Silvia Goldoni et al.   JOURNAL OF CELL BIOLOGY

Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice

(2009) Giovanni Latella et al.   LIVER INTERNATIONAL

Non-Smad pathways in TGF-β signaling

(2008) Ying E Zhang   CELL RESEARCH

Decorin Regulates Endothelial Cell Motility on Collagen I through Activation of Insulin-like Growth Factor I Receptor and Modulation of α2β1 Integrin Activity

(2008) Lorna R. Fiedler et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction

(2008) Liliana Schaefer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY